@article{4dbc15a35305473db08d5b5c3df8979e,
title = "Innovative Approaches to Hypertension Control in Low- and Middle-Income Countries",
abstract = "Elevated blood pressure, a major risk factor for ischemic heart disease, heart failure, and stroke, is the leading global risk for mortality. Treatment and control rates are very low in low- and middle-income countries. There is an urgent need to address this problem. The Global Alliance for Chronic Diseases sponsored research projects focus on controlling hypertension, including community engagement, salt reduction, salt substitution, task redistribution, mHealth, and fixed-dose combination therapies. This paper reviews the rationale for each approach and summarizes the experience of some of the research teams. The studies demonstrate innovative and practical methods for improving hypertension control.",
keywords = "Community engagement, Hypertension, Low- and middle-income countries, Polypill, Salt reduction, Salt substitution, Task redistribution, mHealth",
author = "Rajesh Vedanthan and Antonio Bernabe-Ortiz and Herasme, {Omarys I.} and Rohina Joshi and Patricio Lopez-Jaramillo and Thrift, {Amanda G.} and Jacqui Webster and Ruth Webster and Karen Yeates and Joyce Gyamfi and Merina Ieremia and Claire Johnson and Kamano, {Jemima H.} and Maria Lazo-Porras and Felix Limbani and Peter Liu and Tara McCready and Miranda, {J. Jaime} and Sailesh Mohan and Olugbenga Ogedegbe and Brian Oldenburg and Bruce Ovbiagele and Mayowa Owolabi and David Peiris and Vilarmina Ponce-Lucero and Devarsetty Praveen and Arti Pillay and Schwalm, {Jon David} and Tobe, {Sheldon W.} and Kathy Trieu and Khalid Yusoff and Valentin Fuster",
note = "Funding Information: The writing group thanks Gary Parker from the GACD Secretariat for invaluable logistical and administrative support, and Drs Clara Chow, Pallab Maulik, and Martin McKee for critical review of the article. They also thank all members of the GACD Hypertension Research Program for their support and input throughout the preparation of this article. Funding for the studies described and for article submission was provided by the following GACD Hypertension Program funding agencies: Canadian Institutes of Health Research (Grant No. 120389 ); Grand Challenges Canada (Grant Nos. 0069-04 , and 0070-04 ); International Development Research Centre ; Canadian Stroke Network ; Australian National Health and Medical Research Council (Grant Nos. ID 1040147 , 1040030, 1041052, 104179, and 104018 ); the US National Institutes of Health (National Heart, Lung and Blood Institute and National Institute of Neurological Disorders and Stroke) (Grant Nos. U01 HL114200 , U01 NS079179 , and U01 HL114180 ); the United Kingdom Medical Research Council (Grant Nos. APP 1040179 , APP 1041052 , and J01 60201 ); and the Malaysian Ministry of Higher Education (Long-term Research Grants Scheme 600-RMI/LRGS/5/3). This report does not represent the official view of the National Institute of Neurological Disorders and Stroke, the National Institutes of Health, or any part of the US Federal Government. No official support or endorsement of this article by the National Institutes of Health is intended or should be inferred. Publisher Copyright: {\textcopyright} 2016 Elsevier Inc.",
year = "2017",
month = feb,
day = "1",
doi = "10.1016/j.ccl.2016.08.010",
language = "English",
volume = "35",
pages = "99--115",
journal = "Cardiology Clinics",
issn = "0733-8651",
publisher = "W.B. Saunders Ltd",
number = "1",
}